Items where Author is "Csizmarik, Anita"
Group by: Item Type | No Grouping Jump to: Article Number of items: 18. ArticleFazekas, Tamás and Dér, Bálint and Csizmarik, Anita and Soós, Áron and Fekete, Bálint and Nyirády, Péter and Szarvas, Tibor (2023) Új utak a prosztatarák terápiájában: a genetikai mintázat szerepe a célzott kezelések kiválasztásában = New approaches in the therapy of prostate cancer: The role of genetic patterns in selecting targeted treatments. Magyar Urológia, 35 (2). pp. 75-78. ISSN 0864-8921 Keresztes, Dávid and Csizmarik, Anita and Nagy, Nikolett and Módos, Orsolya and Fazekas, Tamás and Bracht, Thilo and Sitek, Barbara and Witzke, Kathrin and Puhr, Martin and Sevcenco, Sabina and Kramer, Gero and Shariat, Shahrokh F and Küronya, Zsófia and Takács, László and Tornyi, Ilona and Lázár, József and Hadaschik, Boris and Lászik, András and Szűcs, Miklós and Nyirády, Péter and Szarvas, Tibor (2022) Comparative proteome analysis identified CD44 as a possible serum marker for docetaxel resistance in castration-resistant prostate cancer. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 26. pp. 1332-1337. ISSN 1582-1838 Kovács, Petra and Mayer, Tamás and Csizmarik, Anita and Váradi, Melinda and Oláh, Csilla and Széles, Ádám and Tschirdewahn, Stephan and Krafft, Ulrich and Hadaschik, Boris and Nyirády, Péter and Riesz, Péter and Szarvas, Tibor (2022) Elevated Pre-Treatment Serum MMP-7 Levels Are Associated with the Presence of Metastasis and Poor Survival in Upper Tract Urothelial Carcinoma. BIOMEDICINES, 10. No. 698. ISSN 2227-9059 Csizmarik, Anita and Keresztes, Dávid and Nagy, Nikolett and Bracht, Thilo and Sitek, Barbara and Witzke, Kathrin and Puhr, Martin and Tornyi, Ilona and Tímár, József and Takács, László and Kramer, Gero and Sevcenco, Sabina and Maj-Hes, Agnieszka and Jurányi, Zsolt and Hadaschik, Boris and Nyirády, Péter and Szarvas, Tibor (2022) Proteome profiling of enzalutamide-resistant cell lines and serum analysis identified ALCAM as marker of resistance in castration-resistant prostate cancer. INTERNATIONAL JOURNAL OF CANCER. ISSN 0020-7136 Krafft, Ulrich and Oláh, Csilla and Reis, Henning and Kesch, Claudia and Darr, Christopher and Grünwald, Viktor and Tschirdewahn, Stephan and Hadaschik, Boris and Horváth, Orsolya and Kenessey, István and Nyirády, Péter and Váradi, Melinda and Módos, Orsolya and Csizmarik, Anita and Szarvas, Tibor (2021) High Serum PD-L1 Levels Are Associated with Poor Survival in Urothelial Cancer Patients Treated with Chemotherapy and Immune Checkpoint Inhibitor Therapy. CANCERS, 13. No. 2548. ISSN 2072-6694 Csizmarik, Anita and Hadaschik, Boris and Kramer, Gero and Nyirády, Péter and Szarvas, Tibor (2021) Mechanisms and markers of resistance to androgen signaling inhibitors in patients with metastatic castration-resistant prostate cancer. Urologic Oncology, 39 (10). 728.e13-728.e24. ISSN 1078-1439 Oláh, Csilla and Tschirdewahn, Stephan and Hoffmann, Michele and Krafft, Ulrich and Hadaschik, Boris and Nyirády, Péter and Szendrői, Attila and Módos, Orsolya and Csizmarik, Anita and Kovalszky, Ilona and Reis, Henning and Szarvas, Tibor (2021) Soluble Syndecan-1 Levels Are Associated with Survival in Platinum-Treated Bladder Cancer Patients. Diagnostics. No. 864. ISSN 2075-4418 Nagy, Noémi Dalma and Fazekas, Tamás and Baghy, Kornélia and Papp, Gergely and Csizmarik, Anita and Szűcs, Miklós and Nyirády, Péter and Szarvas, Tibor (2021) A karboplatin-kemoterápia hatékonysága egy áttétes, kasztrációrezisztens, BRCA2-mutáció-pozitív prosztatarákos betegben = Efficacy of carboplatin chemotherapy in a metastatic, castration-resistant BRCA2 mutation positive prostate cancer patient. Orvosi Hetilap, 162 (25). pp. 1004-1008. ISSN 0030-6002 Szarvas, Tibor and Csizmarik, Anita and Váradi, Melinda and Fazekas, Tamás and Hüttl, András and Nyirády, Péter and Hadaschik, Boris and Grünwald, Viktor and Tschirdewahn, Stephan and Shariat, Shahrokh F and Sevcenco, Sabina and Maj-Hes, Agnieszka and Kramer, Gero (2021) The prognostic value of serum MMP-7 levels in prostate cancer patients who received docetaxel, abiraterone, or enzalutamide therapy. Urologic Oncology, 39 (5). 296.e11-296.e19. ISSN 1078-1439 Fazekas, Tamás and Csizmarik, Anita and Szarvas, Tibor and Szűcs, Miklós and Nyirády, Péter (2020) A COVID-19-kutatás uroonkológiai vonatkozásai = Uro-Oncologic Aspects of COVID-19 Research. Magyar Urológia, 32 (2). pp. 61-63. ISSN 0864-8921 Szarvas, Tibor and Csizmarik, Anita and Habina-Nagy, Nikolett and Keresztes, Dávid and Váradi, Melinda and Küronya, Zsófia and Riesz, Péter and Nyirády, Péter (2020) Az áttétes kasztrációrezisztens prosztatarák gyógyszer-rezisztenciájának molekuláris vonatkozásai. ORVOSI HETILAP, 161 (20). pp. 813-820. ISSN 0030-6002 Szarvas, Tibor and Hoffmann, Michele and Oláh, Csilla and Székely, Eszter and Kiss, András and Hess, Jochen and Tschirdewahn, Stephan and Hadaschik, Boris and Grotheer, Vera and Nyirády, Péter and Csizmarik, Anita and Váradi, Melinda and Reis, Henning (2020) MMP-7 Serum and Tissue Levels Are Associated with Poor Survival in Platinum-Treated Bladder Cancer Patients. Diagnostics. ISSN 2075-4418 Nagy, Nikolett and Reis, Henning and Hadaschik, Boris and Niedworok, Christian and Módos, Orsolya and Szendrői, Attila and Bíró, Krisztina and Hager, Thomas and Herold, Thomas and Ablat, Jason and Black, Peter and Okon, Krzysztof and Tolkach, Yuri and Csizmarik, Anita and Oláh, Csilla and Keresztes, Dávid and Bremmer, Felix and Gaisa, Nadine T and Kriegsmann, Joerg and Kovalszky, Ilona and Kiss, András and Tímár, József and Szász, Attila Marcell and Rink, Michael and Fisch, Margit and Nyirády, Péter and Szarvas, Tibor (2020) Prevalence of APC and PTEN Alterations in Urachal Cancer. Pathology oncology research : POR, 26. pp. 2773-2781. ISSN 1532-2807 Módos, Orsolya and Bozsaki, Ákos and Nagy, Cintia and Nagy, Nikolett and Csizmarik, Anita and Keresztes, Dávid and Oláh, Csilla and Váradi, Melinda and Horváth, András and Szendrői, Attila and Szűcs, Miklós and Keszthelyi, Attila and Nyirády, Péter and Szarvas, Tibor (2019) A platinaalapú kemoterápia szerepe a húgyhólyagrák kezelésében - az elmúlt 10 év klinikai tapasztalatainak feldolgozása = Platinum-based chemotherapy in urinary bladder cancer - 10 years clinical experiences. Magyar Urológia, 31 (2). pp. 58-65. ISSN 0864-8921 Szarvas, Tibor and Csizmarik, Anita and Szűcs, Miklós and Nyirády, Péter (2019) A prosztatarák molekuláris altípusai és célzott terápiás kilátásai. Orvosi Hetilap, 160 (7). pp. 252-263. ISSN 0030-6002 Szarvas, Tibor and Csizmarik, Anita and Szűcs, Miklós and Nyirády, Péter (2019) A prosztatarák molekuláris altípusai és célzott terápiás kilátásai = Molecular subtypes and perspectives of targeted therapies in prostate cancer. Orvosi Hetilap, 160 (7). pp. 252-263. ISSN 0030-6002 Darr, Christopher and Krafft, Ulrich and Hadaschik, Boris and Tschirdewahn, Stephan and Sevcenco, Sabina and Csizmarik, Anita and Nyirády, Péter and Küronya, Zsófia and Reis, Henning and Maj-Hes, Agnieszka and Shariat, Shahrokh F and Kramer, Gero and Szarvas, Tibor (2018) The Role of YKL-40 in Predicting Resistance to Docetaxel Chemotherapy in Prostate Cancer. UROLOGIA INTERNATIONALIS, 101 (1). ISSN 0042-1138 Szarvas, Tibor and Sevcenco, Sabina and Módos, Orsolya and Keresztes, Dávid and Nyirády, Péter and Csizmarik, Anita (2018) Matrix metalloproteinase 7, soluble Fas and Fas ligand serum levels for predicting docetaxel resistance and survival in castration-resistant prostate cancer. BJU INTERNATIONAL, 122 (4). pp. 695-704. ISSN 1464-4096 (print); 1464-410X (online) |